Clinical Trials Browser

Unknown × Prostatic Neoplasms × Sunitinib × Clear all

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Phase 2 Unknown

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT00550810 2011-12-07

SMART

Phase 2 Unknown

Prostatic Neoplasms